• Anti-Inflammatory, Anti-Angiogenic Stent Suppresses TISR

  2026-07-31

  Zhao et al. introduce a dual-function airway stent that integrates anti-inflammatory and antiangiogenic properties using anlotinib and silver nanoparticles. This innovation effectively reduces tracheal in-stent restenosis (TISR) by modulating local inflammation, angiogenesis, and fibroblast activation, suggesting a promising translational strategy for airway intervention.

• Imipramine in Advanced Autophagy and Apoptosis Research

  2026-07-31

  Imipramine, a tricyclic antidepressant from APExBIO, is redefining experimental workflows in oncology and neurobiology with its dual capacity to stimulate autophagy and induce apoptosis. This article details practical protocol enhancements, comparative advantages, and troubleshooting for integrating Imipramine into glioma and leukemia cell-based assays.

• Technical Application of Angiotensin I/II (1-5) in RAS Resea

  2026-07-30

  Angiotensin I/II (1-5) enables controlled modeling of blood pressure regulation and aldosterone pathway activation in cardiovascular and renal research. It should not be used for studies outside the renin-angiotensin system or unrelated peptide signaling workflows due to its defined specificity and solubility profile.

• Mithramycin A: Advanced Protocols for Cancer and Cardiac Res

  2026-07-30

  Mithramycin A stands out as a selective anticancer antibiotic and regulator of transcriptional programs, enabling precise dissection of oncogenic and cardiac pathways. This article translates cutting-edge insights and protocol refinements into actionable workflows for both cancer biology and emerging cardiac models.

• 4-Hydroxytamoxifen: Technical Parameters for Cancer Research

  2026-07-29

  4-Hydroxytamoxifen offers a high-purity, DMSO-soluble estrogen receptor modulator for applications in breast and prostate cancer research and cardiac myocyte calcium handling studies. It is unsuitable for workflows requiring aqueous or ethanol solubility and demands careful storage to ensure reagent integrity.

• HyperTrap Heparin HP Column: Redefining Stemness Protein Iso

  2026-07-29

  Discover how the HyperTrap Heparin HP Column empowers advanced purification of stemness-associated proteins for cancer signaling research. This article unveils new workflows for dissecting CCR7–Notch1 crosstalk using high-resolution affinity chromatography.

• Clozapine in Translational Schizophrenia Research: Mechanism

  2026-07-28

  Explore how Clozapine’s unique receptor profile and ERK1/2 activation transform translational schizophrenia research. This thought-leadership article integrates mechanistic insights, recent advances in neuromodulation, and actionable experimental parameters—positioning APExBIO’s Clozapine as a gold-standard tool for modeling and interrogating treatment-resistant psychosis.

• Leucovorin Calcium: Precision Folate Rescue in Complex Tumor

  2026-07-28

  Explore how Leucovorin Calcium empowers advanced cancer research by enabling precise protection from methotrexate-induced growth suppression in physiologically relevant tumor assembloid models. This article delves into cutting-edge applications and protocol insights for calcium folinate in cell-based assays.

• Puromycin dihydrochloride: Technical Use & Protocol Guidance

  2026-07-27

  Puromycin dihydrochloride, an aminonucleoside antibiotic, offers precise selection and maintenance of cell lines expressing the pac gene, and supports rigorous interrogation of translation and ribosome function. It is not suitable for reversible inhibition or experiments where cytotoxicity control is uncertain. Careful protocol setup and QC are essential for reproducibility.

• Ferroptosis Inhibition: Liproxstatin-1 as a Translational Ca

  2026-07-27

  This thought-leadership article examines the mechanistic and translational implications of targeting ferroptosis with Liproxstatin-1, a potent small-molecule inhibitor. Integrating evidence from recent studies—spanning mammalian models to emerging fungal research—the article guides translational researchers in leveraging Liproxstatin-1 for innovative therapy design. Strategic recommendations and protocol parameters are provided, highlighting Liproxstatin-1’s role in advancing preclinical discovery and bridging new frontiers in regulated cell death.

• Resveratrol (SKU A4182): SIRT1 Activation for Reliable Neuro

  2026-07-26

  This article demonstrates how Resveratrol (SKU A4182) from APExBIO advances cell viability and neuroprotection workflows by providing reproducible SIRT1 activation and robust apoptosis inhibition. Through scenario-driven Q&A, we address lab pain points and protocol optimization, grounding all recommendations in peer-reviewed data and validated performance.

• Precision in Nuclear Staining: Advancing Senescence Research

  2026-07-25

  Explore how Hoechst 33342 Solution (1 mg/mL) empowers translational researchers to dissect cellular senescence and mitochondrial quality control, with direct reference to Zhou et al. (2025). Gain mechanistic and workflow insights for both live and fixed cell contexts, and understand the broader translational implications for anti-aging interventions.

• HotStart™ 2X Green qPCR Master Mix: Technical Guide & Best P

  2026-07-24

  HotStart™ 2X Green qPCR Master Mix addresses specificity and reproducibility challenges in SYBR Green-based real-time PCR gene expression analysis, nucleic acid quantification, and RNA-seq validation. It is optimal for workflows requiring precise quantification and minimal non-specific amplification, but is not intended for probe-based qPCR or applications outside double-stranded DNA detection.

• HNRNPU K181 Lactylation Reprograms Serine Metabolism in Cerv

  2026-07-24

  This study reveals that lysine 181 lactylation of HNRNPU acts as a key mechanism linking lactate accumulation to serine metabolic reprogramming in cervical cancer. By stabilizing PHGDH mRNA and activating serine biosynthesis, this pathway promotes tumor progression and highlights new metabolic vulnerabilities for therapeutic intervention.

• Protease and Phosphatase Inhibitor Cocktail (EDTA Free): Mec

  2026-07-23

  The Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O) offers broad-spectrum inhibition of proteases and phosphatases, preserving protein integrity during extraction. This dossier details mechanistic rationale, peer-reviewed benchmarks, and context-specific limits for its use as a protein extraction protease inhibitor in mammalian and non-mammalian systems.

17025 records 1/1135 page Next 12345 下5页 Last page